FIELD: medicine.
SUBSTANCE: method involves removing pathological content from urogenital tract. To do it, 4-5 ml of aqueous mixture of iron nanopowder is introduced into urethra for 40-60 min. Then permanent magnetic field is endourethrally applied.
EFFECT: enhanced effectiveness of treatment.
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS | 1996 |
|
RU2139726C1 |
METHOD FOR APPLYING COMPLEX THERAPY OF CHRONIC URETHRITIS PRODUCED BY UROGENITAL INFECTIONS | 2000 |
|
RU2170599C1 |
METHOD FOR TREATING THE CASES OF CHRONIC PROSTATITIS | 2001 |
|
RU2199353C2 |
METHOD FOR TREATMENT OF CHRONIC PROSTATIS | 1998 |
|
RU2172189C2 |
METHOD OF CHRONIC PROSTATITIS TREATMENT | 1997 |
|
RU2143249C1 |
METHOD FOR TREATING THE CASES OF CHRONIC INFECTIOUS PROSTATITIS | 2000 |
|
RU2175862C1 |
METHOD FOR TREATING CHRONIC PROSTATITIS | 2001 |
|
RU2203673C2 |
METHOD FOR COMPLEX TREATMENT OF CHRONIC PROSTATITIS | 2001 |
|
RU2205622C1 |
METHOD FOR DETERMINING THERAPY EFFECTIVENESS IN CHRONIC URETHROGENOUS PROSTATITIS PATIENTS | 1999 |
|
RU2145088C1 |
METHOD AND DEVICE FOR TREATING THE CASES OF CHRONIC PROSTATITIS | 2000 |
|
RU2195971C2 |
Authors
Dates
2006-04-27—Published
2004-05-11—Filed